Company intelligence / Profile preview
Rompharm
- Ownership
- Private
- Development stage
- Commercial
Overview
Rompharm is a Romanian pharmaceutical manufacturer specializing in the development, production, and commercialization of generic medicines. The company operates EU-GMP certified facilities producing ophthalmic solutions/suspensions, injectable solutions in ampoules and syringes, solid oral dosage forms, powders in capsules/sachets/bottles, and specialized oncology medications. It serves over 60 export countries with more than 160 products.
- Therapeutic areas
- OncologyOphthalmologyOther
- Modalities
- Small moleculeBiologic (for sterile solutions and injectables)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Rompharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rompharm.